Recently the drug Oridonin has been found to have anti-inflammatory properties, and therefore, this can serve as a lead for developing new therapeutics against NLRP3-associated diseases such as peritonitis, gouty arthritis and type 2 diabetes. This evidence concerns the gene NLRP3 and type 2 diabetes mellitus.